Q4 revenues are forecast to rise 9.7% for PATH. Despite the topline growth, weak stock momentum and neutral earnings signals have investors largely adopting a hold stance ahead of the report.
Q4 revenues are forecast to rise 9.7% for PATH. Despite the topline growth, weak stock momentum and neutral earnings signals have investors largely adopting a hold stance ahead of the report.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
